InvestorsHub Logo
Followers 119
Posts 9122
Boards Moderated 0
Alias Born 07/17/2005

Re: None

Friday, 06/16/2017 10:33:12 AM

Friday, June 16, 2017 10:33:12 AM

Post# of 14953
Avg. Price Target $14.50 556.11% Upside Sorrento Therapeutics Announces Dismissal Of Lawsuits

SAN DIEGO, June 14, 2017 /PRNewswire/ -- Sorrento Therapeutics (NASDAQ: SRNE) announced today the dismissal of all claims against Sorrento and its Directors contained in the lawsuits brought by Wildcat Liquid Alpha, LLC.

9% short - fun!